Answers are grounded in this paper and cite their sources.
Interview explores how antigen structure and glycosylation affect vaccine performance and immune recognition, suggesting implications for future vaccine strategies.
Advances in mass spectrometry, glycomics, and structural analysis are increasingly informing vaccine antigen characterization and assessment. Working at the interface of regulatory science, analytical characterization, and immunology, John Cipollo explores how antigen structure and glycosylation relate to immune recognition, viral evolution, and vaccine performance.
No takes yet. Share an insight, caveat, or question.
John F. Cipollo (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: